LPSN · As filed with the SEC
Liveperson income statement, by fiscal year
The statement as Liveperson presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Operations · USD thousands, except per-share amounts
| USD thousands, except per-share amounts | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 | FY2019 Year ended Dec 31, 2019 | FY2018 Year ended Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 243,742 | 312,474 | 401,983 | 514,800 | 469,624 | 366,620 | 291,609 | — |
| Costs, expenses and other: | ||||||||
| Cost of revenue | 69,392 | 93,404 | 142,823 | 184,699 | 156,880 | 106,268 | 78,878 | 62,479 |
| Sales and marketing | 75,800 | 100,475 | 125,677 | 214,027 | 165,421 | 149,773 | 156,814 | 103,344 |
| General and administrative | 44,441 | 80,008 | 91,619 | 120,625 | 76,757 | 60,557 | 56,967 | 45,873 |
| Product development | 54,706 | 99,917 | 124,792 | 193,688 | 158,390 | 108,414 | 82,145 | 55,707 |
| Depreciation and amortization | 22,732 | — | — | — | — | — | 16,366 | — |
| Cost of revenue | — | — | — | — | — | — | 8,557 | — |
| Sales and marketing | — | — | — | — | — | — | 1,642 | — |
| General and administrative | — | — | — | — | — | — | 908 | — |
| Product development | — | — | — | — | — | — | 5,259 | — |
| Cost of revenue | — | — | — | — | — | — | 1,138 | 1,143 |
| Impairment of goodwill | 41,595 | 60,551 | 11,895 | — | — | — | — | — |
| Impairment of intangibles and other assets | — | 46,872 | 7,974 | — | — | — | — | — |
| Impairment of intangibles and other assets | 2,108 | — | — | — | — | — | — | — |
| Restructuring costs | 11,667 | 11,139 | 22,664 | 19,967 | 3,397 | 29,420 | 2,043 | 4,468 |
| Amortization of purchased intangibles | — | — | — | — | — | — | — | 1,670 |
| Amortization of purchased intangibles | — | — | — | — | — | — | 1,794 | — |
| Loss (gain) on divestiture | 0 | 558 | (17,591) | — | — | — | — | — |
| Amortization of purchased intangible assets | — | 2,745 | 3,505 | 3,678 | 2,045 | 1,639 | — | — |
| Total costs, expenses and other | 322,441 | 495,669 | 513,358 | 736,684 | 562,890 | 456,071 | 378,641 | 273,541 |
| Loss from operations | (78,699) | (183,195) | (111,375) | (221,884) | (93,266) | (89,451) | (87,032) | (23,703) |
| Other income, net: | ||||||||
| Interest income (expense), net | — | — | 4,669 | (352) | (37,406) | (14,334) | (7,407) | — |
| Interest expense | (31,530) | (14,486) | — | — | — | — | — | — |
| Interest income | 4,751 | 5,860 | — | — | — | — | — | — |
| Gain on troubled debt restructuring | 27,720 | — | — | — | — | — | — | — |
| Gain on debt extinguishment | 0 | 73,083 | — | — | — | — | — | — |
| Other income (expense), net | 13,977 | (12,800) | 10,434 | (1,784) | 3,294 | (1,343) | 1,213 | — |
| Total other income, net | 14,918 | 51,657 | 15,103 | (2,136) | (34,112) | (15,677) | (6,194) | (471) |
| Loss before provision for income taxes | — | — | — | — | — | (105,128) | (93,226) | (24,174) |
| Loss before provision for income taxes | (63,781) | (131,538) | (96,272) | (224,020) | (127,378) | — | — | — |
| Provision for income taxes | 3,452 | 2,735 | 4,163 | 1,727 | (2,404) | 2,466 | 2,845 | 858 |
| Net loss | (67,233) | (134,273) | (100,435) | (225,747) | (124,974) | (107,594) | (96,071) | (25,032) |
| Net loss per share of common stock: | ||||||||
| Basic (in usd per share) | (8.57) | (1.51) | (1.28) | (3.03) | (1.80) | (1.63) | (1.53) | (0.42) |
| Diluted (in usd per share) | (12.39) | (1.51) | (1.28) | (3.03) | (1.80) | (1.63) | (1.53) | (0.42) |
| Weighted-average shares used to compute net loss per share: | ||||||||
| Basic (in shares) | 7,843,700 | 88,715,161 | 78,593,274 | 74,509,404 | 69,606,105 | 65,888,450 | 62,593,026 | 59,203,400 |
| Diluted (in shares) | 8,640,730 | 88,715,161 | 78,593,274 | 74,509,404 | 69,606,105 | 65,888,450 | 62,593,026 | 59,203,400 |
| Stock compensation expense | — | — | — | — | — | — | 44,105 | 14,841 |
| Cost of revenue | — | — | — | — | — | — | 4,218 | 996 |
| Sales and marketing | — | — | — | — | — | — | 10,010 | 5,374 |
| Cost Of Revenue | — | — | — | — | — | — | — | 7,831 |
| General and Administrative | — | — | — | — | — | — | — | 1,083 |
| Product Development | — | — | — | — | — | — | — | 3,754 |
| Sales and Marketing | — | — | — | — | — | — | — | 1,520 |
| General and administrative | — | — | — | — | — | — | 12,216 | 4,921 |
| Product development | — | — | — | — | — | — | 17,661 | 3,550 |
| Revenue | — | — | — | — | — | — | — | 249,838 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.